We are live on ! Find out more
ENFN

Enfusion, Inc.

Delisted

ENFN was delisted on the 17th of April, 2025.

132 hedge funds and large institutions have $1.08B invested in Enfusion, Inc. in 2025 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 51 increasing their positions, 29 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 29

50% more call options, than puts

Call options by funds: $521K | Put options by funds: $348K

40% more funds holding in top 10

Funds holding in top 10: 57 (+2)

16% more capital invested

Capital invested by funds: $939M → $1.08B (+$146M)

0% more funds holding

Funds holding: 132132 (0)

0% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 39

Holders
132
Holders Change
Holders Change %
0%
% of All Funds
1.77%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.09%
New
39
Increased
51
Reduced
29
Closed
39
Calls
$521K
Puts
$348K
Net Calls
+$173K
Net Calls Change
-$994K
Name Holding Trade Value Shares
Change
Change in
Stake
CWM
101
CIBC World Markets
New York
$125K +$124K +11,201 New
ProShare Advisors
102
ProShare Advisors
Maryland
$122K -$33.8K -3,056 -22%
HCA
103
Harbor Capital Advisors
Illinois
$114K +$26.2K +2,366 +30%
FIA
104
FNY Investment Advisers
New York
$111K +$111K +10,000 New
PFSRSONJ
105
Police & Firemen's Retirement System of New Jersey
New Jersey
$109K
AIP
106
Ameritas Investment Partners
Nebraska
$55.3K
PCM
107
PenderFund Capital Management
British Columbia, Canada
$49.8K +$413K +37,400 New
BNP Paribas Financial Markets
108
BNP Paribas Financial Markets
France
$35.8K -$545K -49,299 -94%
Fidelity Investments
109
Fidelity Investments
Massachusetts
$20.7K +$14.7K +1,326 +248%
TRCT
110
Tower Research Capital (TRC)
New York
$19.4K -$127K -11,491 -87%
AB
111
Amalgamated Bank
New York
$19K +$4.08K +369 +27%
GI
112
GAMMA Investing
California
$12.2K +$840 +76 +7%
Carson Wealth (CWM LLC)
113
Carson Wealth (CWM LLC)
Nebraska
$8K +$4.43K +401 +130%
Nisa Investment Advisors
114
Nisa Investment Advisors
Missouri
$3.95K +$1.28K +116 +49%
CIAM
115
Caitong International Asset Management
Hong Kong
$3.62K +$3.34K +302 +1,313%
Jones Financial Companies
116
Jones Financial Companies
Missouri
$2.22K +$2.21K +200 New
Simplex Trading
117
Simplex Trading
Illinois
$2K -$363K -32,825 -99%
Russell Investments Group
118
Russell Investments Group
United Kingdom
$1.82K +$951 +86 +112%
AAM
119
Advisors Asset Management
Colorado
$1.66K -$177 -16 -10%
RIL
120
Rothschild Investment LLC
Illinois
$1.17K +$497 +45 +75%
Royal Bank of Canada
121
Royal Bank of Canada
Ontario, Canada
$1K -$13.8K -1,246 -95%
C
122
Covestor
United Kingdom
$1K -$77 -7 -13%
LC
123
Lindbrook Capital
California
$847 +$840 +76 New
SCM
124
Sterling Capital Management
North Carolina
$558
PFBT
125
Parkside Financial Bank & Trust
Missouri
$558 +$553 +50 New

ENFN Hedge Fund Activity: Q1 2025 in Review

132 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q1 2025, worth a combined $1.08B — up 16% from $939M a quarter earlier.

Fund positioning in ENFN was balanced in Q1 2025: 39 funds opened new positions, 39 closed out, 51 added to existing stakes and 29 trimmed.

The largest buyer was Alpine Associates Management, opening a new position worth an estimated $26.9M. The largest seller was Brown Capital Management, cutting an estimated $22.2M.

  • 132 institutional investors held Enfusion, Inc. (ENFN) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $1.08B of Enfusion, Inc. stock for Q1 2025, up 16% quarter-over-quarter.
  • 39 funds opened new Enfusion, Inc. positions in Q1 2025 and 39 closed out, a net change of 0 holders.
  • The largest Enfusion, Inc. buyer in Q1 2025 was Alpine Associates Management, an estimated $26.9M added.
  • The largest Enfusion, Inc. seller in Q1 2025 was Brown Capital Management, an estimated $22.2M sold.

Based on aggregated 13F filings for Q1 2025.